(0.60%) 5 158.51 points
(0.18%) 38 746 points
(0.66%) 16 263 points
(0.54%) $78.53
(5.04%) $2.25
(0.96%) $2 330.80
(3.47%) $27.62
(-0.14%) $963.95
(-0.06%) $0.928
(-0.42%) $10.83
(-0.13%) $0.796
(-0.11%) $91.35
-10.17% € 0.376
Live Chart Being Loaded With Signals
Pixium Vision SA, a bioelectronics and brain machine interface technology company, specialized in neuromodulation application. It develops PRIMA System, a bionic vision system for patients with severe vision loss due to retinal degeneration caused by the dry atrophic form of Age-related Macular Degeneration (AMD); and to treat bilndness, which replace the normal physiological function of the eye's photoreceptor cells by electrically stimulating the nerve cells of the inner retina, which then transmit the visual information to the brain via the optic nerve...
Stats | |
---|---|
Volumen de hoy | 86 010.00 |
Volumen promedio | 362 912 |
Capitalización de mercado | 1.16M |
EPS | €0 ( 2024-04-18 ) |
Last Dividend | €0 ( N/A ) |
Next Dividend | €0 ( N/A ) |
P/E | -0.0471 |
ATR14 | €0.0810 (21.52%) |
Volumen Correlación
Pixium Vision SA Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Pixium Vision SA Correlación - Moneda/Commodity
Pixium Vision SA Finanzas
Annual | 2022 |
Ingresos: | €2 000.00 |
Beneficio Bruto: | €-805 491 (-40 274.55 %) |
EPS: | €-0.200 |
FY | 2022 |
Ingresos: | €2 000.00 |
Beneficio Bruto: | €-805 491 (-40 274.55 %) |
EPS: | €-0.200 |
FY | 2021 |
Ingresos: | €863 000 |
Beneficio Bruto: | €0.00 (0.00 %) |
EPS: | €-0.230 |
FY | 2020 |
Ingresos: | €1.43M |
Beneficio Bruto: | €1.43M (100.00 %) |
EPS: | €-0.270 |
Financial Reports:
No articles found.
Pixium Vision SA
Pixium Vision SA, a bioelectronics and brain machine interface technology company, specialized in neuromodulation application. It develops PRIMA System, a bionic vision system for patients with severe vision loss due to retinal degeneration caused by the dry atrophic form of Age-related Macular Degeneration (AMD); and to treat bilndness, which replace the normal physiological function of the eye's photoreceptor cells by electrically stimulating the nerve cells of the inner retina, which then transmit the visual information to the brain via the optic nerve. The company has collaboration agreements with Stanford University in California, Institut de la Vision, Moorfields Eye Hospital, Institute of Ocular Microsurgery, University Hospital, and UPMC. Pixium Vision SA was founded in 2011 and is based in Paris, France.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico